Continuing Medical Education > Diabetes Conferences > Advanced Therapeutics Information

Global Advanced Therapeutics and Technologies in
Diabetes Care information

Conference information • Day one schedule • Day two schedule • Day three schedule • Overview • Objectives • Tuition • Return to Global Advanced Therapeutics home page

Overview

This three-day intensive, specialized program meets the unique needs of international physicians by discussing recent advances in therapies and technologies for managing glucose control in patients with type 2 diabetes. The customized program teaches practicing doctors how to select appropriate candidates, start and adjust treatment, and monitor changes in glycemic control using advanced therapies focusing on incretin-based therapies. Opportunities to interact with patients who have experience with advanced therapies and technologies will be provided. IDC faculty work closely with participants throughout the program and are available during program breaks and meals for in-depth discussions.

The program introduces the latest glucose monitoring technology, continuous glucose monitoring (CGM), and a novel approach to its representation and analysis, ambulatory glucose profile (AGP). The advanced therapy, combined with new technology, provides a unique perspective on diabetes management.

Objectives

Following this program, participants should be able to:

• describe where incretin-based therapy fits within the treatment of type 2 diabetes by customizing a clinical decision path
• interpret an ambulatory glucose profile from continuous glucose monitoring (CGM) data by identifying glycemic patterns
• evaluate the relationship between medication selection and patient behavior, to counsel the patient about changes in lifestyle when using incretin-based therapies

Tuition

US $2,000 per participant. Includes:

• Meals and snacks during program: breakfast, full lunch, refreshments
• Group transportation to and from conference hotel in downtown Minneapolis
• Program materials
• Comprehensive syllabus
• Staged Diabetes Management: A Systematic Approach
• Staged Diabetes Management: Adult Quick Guide (5th Edition)
• Incorporating Incretin-based Therapies Into Practice monograph
• Ongoing communication through Staged Diabetes Management global Web site
• Network with other program participants
• Monthly electronic newsletter
• Access to Web-based ambulatory glucose profile (AGP) software (when available – in 2010)

Program participants are responsible for:

• airline transportation to and from Minneapolis
• hotel accommodations (information regarding conference hotel will be provided when registering)
• meals, local transportation and other expenses not included in the program tuition

To register or request additional information, contact:

Dina Melnik, Senior Program Coordinator
International Diabetes Center
E-mail: dina.melnik@parknicollet.com
Phone: 952-993-1107
Fax: 952-993 -1302